Biomarkers Utility: At the Borderline between Cardiology and Neurology

Biomarkers are important diagnostic and prognostic tools as they provide results in a short time while still being an inexpensive, reproducible and accessible method. Their well-known benefits have placed them at the forefront of research in recent years, with new and innovative discoveries being im...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Adriana Ion, Celina Stafie, Ovidiu Mitu, Cosmina Elena Ciobanu, Dan Iliescu Halitchi, Alexandru Dan Costache, Cezara Bobric, Roxana Troase, Ivona Mitu, Bogdan Huzum, Stefania Teodora Duca, Irina Iuliana Costache
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
BNP
Acceso en línea:https://doaj.org/article/259c155f500b430eab5211a90846d72d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:Biomarkers are important diagnostic and prognostic tools as they provide results in a short time while still being an inexpensive, reproducible and accessible method. Their well-known benefits have placed them at the forefront of research in recent years, with new and innovative discoveries being implemented. Cardiovascular and neurological diseases often share common risk factors and pathological pathways which may play an important role in the use and interpretation of biomarkers’ values. Among the biomarkers used extensively in clinical practice in cardiology, hs-TroponinT, CK-MB and NTproBNP have been shown to be strongly influenced by multiple neurological conditions. Newer ones such as galectin-3, lysophosphatidylcholine, copeptin, sST2, S100B, myeloperoxidase and GDF-15 have been extensively studied in recent years as alternatives with an increased sensitivity for cardiovascular diseases, but also with significant results in the field of neurology. Thus, given their low specificity, the values interpretation must be correlated with the clinical judgment and other available investigations.